Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

Synthesis of DNA-Encoded Macrocyclic Peptides via Visible-Light-Mediated Desulfurative C-C Bond Formation

Macrocyclizing DNA-Encoded Peptides via Visible-Light-Mediated Desulfurisation

Synthesis of DNA-Encoded Macrocyclic Peptides via Nitrile-Aminothiol Click Reaction

Constructing Head-to-Tail Cyclic Peptide DNA-Encoded Libraries Using Two-Directional Synthesis Strategy

Design and Application of a DNA-Encoded Macrocyclic Peptide Library

Peptide Macrocyclization via Intramolecular Interception of Visible-Light-Mediated Desulfurization

Macrocyclic Peptide Construction Through C-H Activation Strategy.

Semi-synthesis of a DNA-Tagged Polyketide-Peptide Hybrid Macrocycle Using a Biosynthetically Prepared Fungal Macrolide as a Synthetic Component

sp3‐Rich Heterocycle Synthesis on DNA: Application to DNA‐Encoded Library Production

Peptide Macrocyclisation via Intramolecular Interception of Visible-Light-Mediated Desulfurisation

Synthesis and Structural Characterization of Macrocyclic α-ABpeptoids and Their DNA-Encoded Library

Biosynthetic Strategies for Macrocyclic Peptides

Genetically programmed cell-based synthesis of non-natural peptide and depsipeptide macrocycles

Recent Developments in Peptide Macrocyclization

Anhydrous Carbene Insertion Reactions: A New Synthetic Platform for DNA‐Encoded Library

Peptide Macrocyclization Through Palladium-Catalyzed Late-Stage C-H Activation.

Squaramide Formation for DNA-Encoded Library Synthesis

A Convenient Method for Synthesis of Tetraoxazole Peptide Macrocycles

Exploiting Chemical Diversity Through C–H Activation and DNA-Encoding

De Novo Sequencing of Synthetic Bis -cysteine Peptide Macrocycles Enabled by "Chemical Linearization" of Compound Mixtures

Backbone-Enabled Peptide Macrocyclization Through Late-Stage Palladium-Catalyzed C-H Activation